Aptus Capital Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
Aptus Capital Advisors's CL Position: Q2 2026 in Review
Aptus Capital Advisors increased its Colgate-Palmolive (CL) stake by 0.03% in Q2 2026, buying an estimated $2.27K and bringing the position to 79,780 shares worth $7.31M. The position accounts for 0.05% of the portfolio, ranked #283.
Aptus Capital Advisors first reported a position in CL in Q1 2022 and has held it in 15 quarters since. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Aptus Capital Advisors held 79,780 shares of Colgate-Palmolive worth $7.31M as of Q2 2026.
- Aptus Capital Advisors bought 26 Colgate-Palmolive shares in Q2 2026, an estimated $2.27K.
- Colgate-Palmolive made up 0.05% of Aptus Capital Advisors's portfolio in Q2 2026, its #283 holding.
- Aptus Capital Advisors first reported a position in Colgate-Palmolive in Q1 2022 and has held it in 15 quarters since.
- 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.